Featured Suppliers

Medtronic Inc

Novo Nordisk Inc

Becton, Dickinson and Company - BD

Sandoz

Ipsen

Philips Medical Systems

Horphag

Smiths Medical

May

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

AACE 21st Annual Meeting and Clinical Congress

23 May 2012

ADA 2012 - 72nd Scientific Sessions

8 June 2012

The Endocrine Society, Annual Meeting 2012

23 June 2012

Potential Breast Cancer Vaccine Combination Therapy New Inflammation Hormone Link May Pave Way To Study New Drugs For Type 2... Changes In Flies Parallel Sundown Syndrome Which May Be Due To High Dopamine... Infant Testosterone Levels Impacted More By Environmental Factors Than Genetics Research With Infant Twins Shows That Environmental Conditions Determine... Controlling The Action Of Estrogen, Key Risk Factor For Endometrial And Breast... Testosterone Treatment Helps Obese Older Males Lose Weight, Other Health Gains... Men With Low Testosterone Levels May Be At Increased Risk For Diabetes Prostate Cancer Stem Cells Identified Among Low-PSA Cells Understanding Of Breast Cancer's Multiple Varieties Improved By New Data

Touch Endocrinology

Biphasic Insulin Aspart
Hypoglycemia Type 2 Diabetes
Glucose Monitoring
Incretin-based Therapies

Biphasic Insulin Aspart

Clinical Experience with Biphasic Insulin Aspart 30 (NovoMix® 30)

Robert Ligthelm

European Endocrinology, 2011;7(2):119-120

Hypoglycemia Type 2 Diabetes

Hypoglycemia in Type 2 Diabetes—Consequences and Risk Assessment

Ildiko Lingvay

US Endocrinology, 2011;7(2):95-102

Glucose Monitoring

Use of Continuous Glucose Monitoring Can Address Patient Fears and Facilitate Improved Glycaemic Management

Jeff Unger, Chris Parkin

European Endocrinology, 2011;7(2):88-91

Incretin-based Therapies

Incretin-based Therapies for Type 2 Diabetes—Comparisons Between Glucagon-like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors

Timothy Bailey

US Endocrinology, 2011;7(2):82-94

Editor's choice

The Challenge of Managing Hypertension in Patients with Diabetes or Other Endocrine Disorders

Enrico Agabiti Rosei et al.

US Endocrinology, 2011;7(1):46-50

Also in Editor's Choice

Advances in the Understanding of Adult Growth Hormone Deficiency Syndrome – Diagnosis, Epidemiology and Management

Can Blood Glucose Monitoring be Simplified/Modified in Order to Achieve Better Diabetes Management—Perspectives for the Future

Gonadotrophic Hormones – An Overview of their Involvement in Gonadal and Extragonadal Tumours

The Challenge of Managing Hypertension in Patients with Diabetes or Other Endocrine Disorders

Latest Articles

Early Glomerular Filtration Rate Loss as a Marker of Diabetic Nephropathy

George Jerums, Elif Ekinci, Sianna Panagiotopoulos, Richard J MacIsaac

Blood Glucose Monitoring In Pediatric Patients— Looking Toward Better Diabetes Management and Perspectives for the Future

William L Clarke

When Will We Agree on the Origin and Meaning of ‘Wellbeing’?

Robert Knutzen, Lewis S Blevins

In Pursuit of an Ideal – A Perspective on Non-Invasive Continuous Glucose Monitoring

Lisa B English

Lixisenatide—Once-daily Glucagon-like Peptide-1 Receptor Agonist in the Management of Type 2 Diabetes

Celeste C L Quianzon, Mansur E Shomali